Utility Of Routine Serum Free Light Chain Assay For Amyloidosis In Patients With Heart Failure
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY(2017)
Abstract
Background: Light-chain amyloidosis (AL) is thought to be a rare disease with a prevalence of 8-10 per million patient years. Cardiac involvement is an important prognostic factor. The serum free light chain assay (FLC) is inexpensive and recommended as an initial diagnostic test when AL is
MoreTranslated text
Key words
amyloidosis,free light chain assay,heart failure,routine serum
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined